Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0

Revue du rhumatisme
Volume 71, n° 5
pages 330-332 (mai 2004)
Doi : 10.1016/j.rhum.2003.11.002
Received : 22 August 2003 ;  accepted : 7 November 2003
Anticorps antiphospholipides : progrès récents concernant leur origine et leur pathogénicité
Antiphospholipid antibodies: reçent progresses on their origin and pathogenicity " onClick="javascript:init_clueTip($j(this));" rel=".tooltip-art-idFN0">

Jean-Louis  Pasquali * ,  Hélène  Nehme,  Anne-Sophie  Korganow,  Thierry  Martin
Laboratoire d'immunopathologie Inserm EMI 0222, service de médecine interne et d'immunologie clinique, clinique médicale A, hôpitaux universitaires de Strasbourg, 67091 Strasbourg, France 

*Auteur correspondant.

Mots clés  : Anticorps antiphospholipides ; Syndrome des antiphospholipides.

Mots clés  : Anti-phospholipid antibodies ; Anti-phospholipid syndrome.

  Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine.

© 2003  Elsevier SAS. All Rights Reserved.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline